GLP-1(32-36)amide

Modify Date: 2025-08-25 18:33:58

GLP-1(32-36)amide Structure
GLP-1(32-36)amide structure
Common Name GLP-1(32-36)amide
CAS Number 1417302-71-6 Molecular Weight 570.73
Density N/A Boiling Point N/A
Molecular Formula C25H50N10O5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GLP-1(32-36)amide


GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide could inhibit weight gain and modulate whole body glucose metabolism in diabetic mice[1][2].

 Names

Name GLP-1(32-36)amide

 GLP-1(32-36)amide Biological Activity

Description GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide could inhibit weight gain and modulate whole body glucose metabolism in diabetic mice[1][2].
Related Catalog
In Vitro GLP-1(32-36)amide (0.1-10 μM; 24 h) retains cell viability and decreases apoptosis against Streptozotocin (STZ; 1 μM) in INS‐1 cells[2]. Cell Viability Assay[2] Cell Line: INS‐1 cells Concentration: 0.1, 1, 10 μM Incubation Time: 24 hours Result: Decreased cell viability only approximately 30% in 0.1 μM and approximately 20% in ≥1 μM while approximately 45% in saline-treated controls.
In Vivo GLP-1(32-36)amide (1 μmol/kg; i.p. once daily for 21 d) protects islet from damage, inhibits weight gain, and relieves symptoms of polydipsia in diabetic mice[2]. GLP-1(32-36)amide (1 μmol/kg; a single i.p.) slightly reduces the mean glucose lever at 30 min after the challenge of glucose in normal mice[2]. GLP-1(32-36)amide (50-70 nmol/kg/d; infusion for 12-16 weeks) prevents the development of diet-induced obesity and hepatic steatosis in high fat-fed mice[3]. Animal Model: Male KM mice (6-8 weeks; 18-22 g) injected with STZ[2] Dosage: 1 μmol/kg Administration: I.p. once daily for 21 days Result: Significantly lowered the cumulative values of food and water intake. Lowered fasting glucose. Reduced the level of Hemoglobin A1c (HbA1c). Improved glucose tolerance. Suppressed body weight gain.
References

[1]. Elahi D, et, al. GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs. Peptides. 2014 Sep;59:20-4.

[2]. Sun L, et, al. Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice. Chem Biol Drug Des. 2015 Dec;86(6):1482-90.

[3]. Tomas E, et, al. GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice. Diabetes. 2015 Jul;64(7):2409-19.

 Chemical & Physical Properties

Molecular Formula C25H50N10O5
Molecular Weight 570.73
InChIKey VCMIHDDYZTYYJC-JPLJXNOCSA-N
SMILES CC(C)CC(N)C(=O)NC(C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(N)=O)C(C)C
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

GLP-1(32-36)amide suppliers


Price: ¥2750/5 mg

Reference only. check more GLP-1(32-36)amide price